Biotech

All Articles

Cullinan, after $25M deal, return bispecific to Port

.Cullinan Therapy was actually excited good enough with Port BioMed's bispecific immune activator th...

A closer check out Fierce Biotech's Brutal 15

.Within this week's incident of "The Best Line," our company are actually diving in to Brutal Biotec...

Lilly encounters phase 2 failure of tau-targeting med

.The confetti is still flying from Eli Lilly's party celebrating the commendation of Alzheimer's ail...

Biogen CMO Maha Radhakrishnan signs up with Sofinnova-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our roundup of substantial management hirings, shootings as...

Lykos will certainly talk to FDA to reconsider its own selection complying with turndown of MDMA treatment for post-traumatic stress disorder

.Observing an inadequate presenting for Lykos Therapies' MDMA applicant for trauma at a current FDA ...

AN 2 halves census, ceases phase 3 trial after information dissatisfy

.AN2 Rehabs is reconsidering its company in reaction to uninspired midphase records, promising to la...

Merck pays $700M for bispecific, snooping autoimmune opening and also opportunity to test Amgen in cancer

.Merck &amp Co. is actually paying $700 thousand beforehand to test Amgen in a blood cancer market. ...

Gilead pays J&ampJ $320M to go out licensing bargain for seladelpar

.With Gilead Sciences almost an FDA selection for its liver ailment medicine seladelpar, the firm ha...

' All hands on deck' at Lilly as peers target excessive weight market

.CEO David Ricks can easily view the companies establishing outdoors tents at basecamp behind Eli Li...

Entero laying off team, moving out of workplace and also stopping R&ampD

.Bed Liquidators has actually turned Entero Rehabs white as a sheet. The collector ordered Entero to...